<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>STORRE Collection: Electronic copies of Faculty of Health Sciences and Sport Technical Reports</title>
  <link rel="alternate" href="http://hdl.handle.net/1893/21456" />
  <subtitle>Electronic copies of Faculty of Health Sciences and Sport Technical Reports</subtitle>
  <id>http://hdl.handle.net/1893/21456</id>
  <updated>2026-09-25T08:08:35Z</updated>
  <dc:date>2026-09-25T08:08:35Z</dc:date>
  <entry>
    <title>Alcohol consumption  and sustainable  development</title>
    <link rel="alternate" href="http://hdl.handle.net/1893/37321" />
    <author>
      <name>Ferreira-Borges, Carina</name>
    </author>
    <author>
      <name>Neufeld, Maria</name>
    </author>
    <author>
      <name>Breda, Joao</name>
    </author>
    <author>
      <name>Madureira Lima, Joana</name>
    </author>
    <author>
      <name>Aragon De Leon, Emilia</name>
    </author>
    <id>http://hdl.handle.net/1893/37321</id>
    <updated>2025-09-21T01:12:11Z</updated>
    <published>2020-10-01T00:00:00Z</published>
    <summary type="text">Title: Alcohol consumption  and sustainable  development
Author(s): Ferreira-Borges, Carina; Neufeld, Maria; Breda, Joao; Madureira Lima, Joana; Aragon De Leon, Emilia
Editor(s): World Health Organization. Regional Office for Europe,
Abstract: Alcohol is a psychoactive and dependence-producing substance that is classified as a Group 1 human carcinogen and has a significant global impact on population health (1,2).  Harmful use of alcohol is broadly defined as “drinking that causes detrimental health and social consequences for the drinker, the people around the drinker and society at large, as well as patterns of drinking that are associated with increased risk of adverse health consequences”. This definition references effects beyond clinical context, highlighting that alcohol use is one of the leading risk factors for population ill health, disability and death worldwide. It emphasizes that alcohol affects not only consumers but also many third parties, including victims of road crashes or violence and children born with fetal alcohol spectrum disorders or in families with parental alcohol problems; alcohol use also leads to increased health-care costs and productivity losses.  Alcohol is recognized as a cause for more than 200 diseases and injuries in the International Classification of Diseases, with at least 40 diseases and injuries being 100% attributable to alcohol (1,5). The burden of alcohol-attributable mortality stems from two broader categories: the chronic noncommunicable diseases (NCDs; neurological disorders, cancer, cardiovascular diseases and cirrhosis of the liver) and the acute group of unintentional and intentional injuries (1,6).  Adverse effects of alcohol consumption are visible even in early life, being one of the leading causes of premature mortality in road traffic accidents, falls, drowning, suicides and other external causes. In the WHO European Region, close to one in four deaths of young adults aged 20–24 years is caused by alcohol.  The WHO Global strategy to reduce the harmful use of alcohol, negotiated and agreed by all Member States in 2010, represents the international consensus that reducing the harmful use of alcohol and its associated health and social burden is a public health priority. The European action plan to reduce the harmful use of alcohol 2012–2020 (EAPA) complements the Global Strategy and gives tailored guidance for Member States of the WHO European Region.</summary>
    <dc:date>2020-10-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>United Kingdom Drug Situation 2014 edition. UK Focal Point on Drugs annual report to the European Monitoring Centre for Drugs and Drug Abuse</title>
    <link rel="alternate" href="http://hdl.handle.net/1893/37293" />
    <author>
      <name />
    </author>
    <id>http://hdl.handle.net/1893/37293</id>
    <updated>2025-09-21T01:13:44Z</updated>
    <published>2014-01-02T00:00:00Z</published>
    <summary type="text">Title: United Kingdom Drug Situation 2014 edition. UK Focal Point on Drugs annual report to the European Monitoring Centre for Drugs and Drug Abuse
Editor(s): Burton, Robyn; Thomson, Fay; Visintin, Cristina; Wright, Craig
Abstract: The structure and content of this annual report are pre-determined by the EMCDDA to facilitate comparison with similar reports produced by the other European Focal Points. Ten chapters cover the same subjects each year.  Each of the first 10 chapters begins with an Introduction. This sets the context for the remainder of the chapter, describing the main features of the topic under consideration within the UK. This may include information about the main legislative and organisational frameworks, sources of data and definitions used, the broad picture shown by the data and recent trends.  The remainder of each chapter is concerned with New Developments and Trends that have not been included in previous annual reports. Generally, this covers developments that have occurred in the second half of 2013 or the first half of 2014. Relevant data that have become available during this period will also be discussed although these will often refer to earlier time periods.  This report, and the reports from the other European countries, will be used in the compilation of the EMCDDA’s annual report of the drug situation in the European Union (EU) and Norway to be published in 2015.</summary>
    <dc:date>2014-01-02T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>United Kingdom Drug Situation 2013 edition. UK Focal Point on Drugs annual report to the European Monitoring Centre for Drugs and Drug Abuse</title>
    <link rel="alternate" href="http://hdl.handle.net/1893/37290" />
    <author>
      <name />
    </author>
    <id>http://hdl.handle.net/1893/37290</id>
    <updated>2025-09-21T01:13:21Z</updated>
    <published>2013-01-02T00:00:00Z</published>
    <summary type="text">Title: United Kingdom Drug Situation 2013 edition. UK Focal Point on Drugs annual report to the European Monitoring Centre for Drugs and Drug Abuse
Editor(s): Davies, Charlotte; Murray, Rosemary
Abstract: The structure and content of this annual report are pre-determined by the EMCDDA to facilitate comparison with similar reports produced by the other European Focal Points. Ten chapters cover the same subjects each year.  Each of the first ten chapters begins with an Introduction. This sets the context for the remainder of the chapter, describing the main features of the topic under consideration within the United Kingdom. This may include information about the main legislative and organisational frameworks, sources of data and definitions used, the broad picture shown by the data and recent trends.  The remainder of each chapter is concerned with New Developments and Trends that have not been included in previous annual reports. Generally, this covers developments that have occurred in the second half of 2012 or the first half of 2013. Relevant data that have become available during this period will also be discussed although these will often refer to earlier time periods.  This report, and the reports from the other European countries, will be used in the compilation of the EMCDDA’s annual report of the drug situation in the European Union and Norway to be published in 2014</summary>
    <dc:date>2013-01-02T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Monitoring alcohol consumption and harm during the COVID pandemic</title>
    <link rel="alternate" href="http://hdl.handle.net/1893/37236" />
    <author>
      <name>Burton, Robyn</name>
    </author>
    <author>
      <name>Sharpe, Casey</name>
    </author>
    <author>
      <name>Amasiatu, Chioma</name>
    </author>
    <author>
      <name>White, Martin</name>
    </author>
    <author>
      <name>Cook, Mark</name>
    </author>
    <author>
      <name>Griffiths, Clare</name>
    </author>
    <author>
      <name>Khetani, Meetal</name>
    </author>
    <author>
      <name>Clarke, Zoe</name>
    </author>
    <author>
      <name>Henn, Clive</name>
    </author>
    <author>
      <name>Sheron, Nick</name>
    </author>
    <id>http://hdl.handle.net/1893/37236</id>
    <updated>2025-07-23T00:05:53Z</updated>
    <published>2021-07-15T00:00:00Z</published>
    <summary type="text">Title: Monitoring alcohol consumption and harm during the COVID pandemic
Author(s): Burton, Robyn; Sharpe, Casey; Amasiatu, Chioma; White, Martin; Cook, Mark; Griffiths, Clare; Khetani, Meetal; Clarke, Zoe; Henn, Clive; Sheron, Nick
Abstract: This report collates data on alcohol consumption and alcohol-related harm in England throughout the coronavirus (COVID-19) pandemic and compares it to data from previous years.  The report’s aim is to understand how indicators of alcohol consumption and harm have changed while the social and physical restrictions to prevent and control COVID-19 were in place. These restrictions led to changes in the availability of alcohol, most notably the approximately 31-week closure of on-trade premises, such as pubs and restaurants, during national lockdowns</summary>
    <dc:date>2021-07-15T00:00:00Z</dc:date>
  </entry>
</feed>

